Navigation Links
Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
Date:10/12/2009

ple Myeloma

Multiple myeloma (MM) is the second most common hematologic cancer and results from an abnormality of plasma cells, usually in the bone marrow. In the United States, more than 50,000 people are living with MM and approximately 20,000 new cases are diagnosed annually(i). Worldwide, more than 180,000 people are living with MM and approximately 86,000 new cases are diagnosed annually(ii).

About Carfilzomib

Carfilzomib is the first in a new class of highly specific proteasome inhibitors. Carfilzomib produces specific and sustained inhibition of the proteasome, leading to apoptosis in cancer cells with minimal off-target effects. In Phase 1 and Phase 2 clinical trials, carfilzomib has demonstrated single-agent activity in hematologic and solid tumors, including multiple myeloma and renal cancer. Proteolix is currently conducting a comprehensive clinical development program evaluating carfilzomib for the treatment of multiple myeloma, including two ongoing Phase 2 clinical trials of single-agent carfilzomib, one in heavily pre-treated relapsed and refractory patients with progressive disease who have failed to respond to prior treatment, and a second in relapsed patients stratified by prior treatment with bortezomib. A Phase 1b clinical trial of carfilzomib in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma is also ongoing. In addition, based on promising Phase 1 results, Proteolix is conducting a single-agent Phase 1b/2 clinical trial of carfilzomib in patients with recurrent or advanced solid tumors. For the latest information regarding ongoing carfilzomib clinical trials, please visit www.clinicaltrials.gov.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is devel
'/>"/>

SOURCE Proteolix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Reportlinker Adds Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) Report
2. To: All Persons and Entities Who Purchased or Acquired Bristol-Myers Common Stock Between the Close of the Market on March 21, 2006, Through August 8, 2006, Inclusive
3. Avacor(R), Premier Provider of Hair Growth Solutions, Acquired By Investor Group.
4. Blue Cross Blue Shield of Michigan-owned DenteMax Acquired by Dental Network of America
5. Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community-acquired Bacterial Pneumonia (CABP) Requiring Hospitalization
6. Despite Generic Erosion of Key Brands, the Hospital-Acquired Gram Negative Infections Drug Market Will Increase by $1 Billion from 2008 to 2018
7. MedServe to be Acquired by Stericycle for $185 Million
8. Brockton Mayor, James E. Harrington Calls Press Conference to Unveil Newly Adopted Auto Emissions Technology Acquired With Federal Stimulus Money
9. Versailles Group Announces Accentus, Inc. Acquired by High Road Capital Partners
10. All Persons Who Purchased or Acquired the Common Stock of Sunrise Senior Living, Inc. (Sunrise) Between February 26, 2004 and July 28, 2006, Inclusive, and Were Damaged Thereby (The Class)
11. Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... "My niece developed a nighttime fever, and I ... fever might get worse," said an inventor from Montgomery, ... how she was doing, I developed this monitoring system." ... a child's temperature. The unit instantly alerts parents if ... medical care can be given, which is designed to ...
(Date:8/30/2014)... York (PRWEB) August 30, 2014 Bringing ... Profit By Search announces the Labor Day discount ... clients will surely get the complete services related to ... SEO professionals, Content Writers, and others do have a ... perfection that reflects in their work and since the ...
(Date:8/30/2014)... "I had a handicapped friend who could not walk ... from Wetumpka, Ala. "In order to help her be able ... came up with a way for her to use her ... the patent-pending Deezers to allow crutches to be used on ... walkers, or canes at the beach. The device reduces the ...
(Date:8/30/2014)... Bethesda, MD (PRWEB) August 30, 2014 In ... and increasingly difficult to get. Snoring and sleep apnea (a ... stops) robs people and their bed partners of the rest ... to 45% of the population snores and 20 million people ... only 10% have been diagnosed and treated; and of those ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 One of the ... era is the gluten-free diet. Originally meant for sufferers of ... a catchall for people who are looking to get healthier ... not only is this kind of information erroneous, it also ... problems because of a drastic change in their food ...
Breaking Medicine News(10 mins):Health News:Profit By Search Announces Labor Day Discount on SEO Services 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2
... 21 As the pace of global,competition ... research,groups to keep up. Effective market research ... customers, markets and competitors as,reference points to ... from benchmarking leader Best Practices, LLC., ...
... got easier and a lot more accessible to the public ... a ground-breaking partnership between a young British entrepreneur, a global ... , Debuted April 20 to offer individuals a meaningful way ... hope www.MalariaEngage.org will do for African research what ...
... Don,t eat for 2, because complications increase with excess weight, ... been considered a kind of gastronomical free-for-all. After all, ... food she eats, right? , The problem is, the ... and extra weight gain can increase the risk of pregnancy ...
... J. Deitsch, Chairman,and Chief Executive Officer of Nutra ... will be updating the investment,community through his personal ... dynamic profile will include exclusive interviews with,Rik J. ... his personal,stock watchlist, photos of company products and ...
... Sales force performance,significantly impacts growth and ... to effectively disseminate vital information to their ... to the overall success of,their companies., ... Excellence:,Resources, Structure and Processes to Optimize Pharmaceutical ...
... point to the brain-draining effects of decision-making , , FRIDAY, April ... flavors of ice cream, people,s lives are full of choices. ... sap your stamina, your ability to stay focused and even ... people faced with a variety of choices had more trouble ...
Cached Medicine News:Health News:Creating an Effective Market Research Group to Generate High-Impact Business Results 2Health News:International health experts to enlist the public in war on African malaria 2Health News:International health experts to enlist the public in war on African malaria 3Health News:International health experts to enlist the public in war on African malaria 4Health News:International health experts to enlist the public in war on African malaria 5Health News:International health experts to enlist the public in war on African malaria 6Health News:International health experts to enlist the public in war on African malaria 7Health News:International health experts to enlist the public in war on African malaria 8Health News:Extra Pounds During and Between Pregnancies Can Pose Problems 2Health News:Extra Pounds During and Between Pregnancies Can Pose Problems 3Health News:Rik Deitsch, CEO of Nutra Pharma Creates Personal Wall on WallSt.net's Financial Social Community, my.wallst.net 2Health News:Complementary Excerpt Available from Best Practices: Resources, Structure and Processes to Optimize Pharmaceutical Sales Communications 2Health News:Choices Sap Your Stamina, Self Control: Study 2Health News:Choices Sap Your Stamina, Self Control: Study 3
(Date:8/29/2014)... Aug. 29, 2014  A Boston Scientific Corporation ... on stent removability and preliminary long term stricture ... in the August issue of the peer-reviewed journal, ... is being conducted in 11 countries and ... self-expanding metal stents (FCSEMS) after extended indwell (i.e., ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Research and Development Trend Forecast of Pharmaceutical ... offering. Research and Development Trend Forecast ... , 2014-2018 mainly analyzes China,s ... status, supply & demand, competition landscape, and business performance ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4China Orthopedic Instrument Industry Report, 2014-2017 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... Pharmaceuticals, Inc. (Nasdaq: ACRX ), a specialty ... innovative therapies for the treatment of acute and breakthrough ... Executive Officer, will present at the 23 rd ... City at the New York Palace Hotel.  The presentation ...
... 23, 2011 Reportlinker.com announces that ... available in its catalogue: ... Devices Industry 2011–2012: Market Trends and ... Devices Industry Procurement and Marketing Initiatives ...
Cached Medicine Technology:AcelRx Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference 2Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 2Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 3Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 4Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 5Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 6Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 7Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 8Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 9Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 10Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 11Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 12Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 13Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 14Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives 15
... Difficile Tox A/B II is a second-generation rapid ... A and B in fecal specimens. The test ... results detecting not only the more common toxin ... A-/B+. It's easy to perform, produces no indeterminates ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... testing feature single-well ANA screen and ENA ... tests including dsDNA, and 6 individual ENA ... Scl-70 and Jo-1. In addition, our autoimmune ... products for Cardiolipins (IgA, IgG, IgM), Thyroglobulin, ...
Medicine Products: